Publication Name	World Journal of Gastroenterology
Manuscript ID	19213
Country	Italy

Received	2015-05-03 15:23
Peer-Review Started	2015-05-07 18:10
To Make the First Decision	2015-06-23 15:00
Return for Revision	2015-06-26 17:11
Revised	2015-07-12 20:19
Second Decision	2015-09-13 22:23
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-09-15 13:41
Articles in Press	2015-09-15 13:41
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-09-22 10:17
Publish the Manuscript Online	2015-10-14 12:06

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Infectious Diseases
Manuscript Type	Topic Highlights
Article Title	Impact of new treatment options for hepatitis C virus infection in liver transplantation
Manuscript Source	Invited Manuscript
All Author List	Elda Righi, Angela Londero, Alessia Carnelutti, Umberto Baccarani and Matteo Bassetti
Funding Agency and Grant Number
Corresponding Author	Elda Righi, MD, PhD, Infectious Diseases Division, Santa Maria della Misericordia University Hospital, 50 Colugna Street, 33100 Udine, Italy. elda.righi@libero.it
Key Words	Hepatitis C virus; Direct antiviral agents; Liver transplantation
Core Tip	Until recently, a well-tolerated and effective treatment protocol to address the recurrence of hepatitis C virus (HCV) infection following liver transplantation has been an important unmet clinical need. Safe and effective treatment options are now available thanks to the approval of new classes of direct antiviral agents. The aim of this review was to summarize the outcome of previous treatments and discuss the impact of current options for the treatment of HCV among liver transplantation candidates and recipients, including coinfected human immunodeficiency virus/HCV patients.
Publish Date	2015-10-14 12:06
Citation	Righi E, Londero A, Carnelutti A, Baccarani U, Bassetti M. Impact of new treatment options for hepatitis c virus infection in liver transplantation. World J Gastroenterol 2015; 21(38): 10760-10775
URL	http://www.wjgnet.com/1007-9327/full/v21/i38/10760.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i38.10760

Full Article (PDF)	WJG-21-10760.pdf
Full Article (Word)	WJG-21-10760.doc
Manuscript File	19213-Review.docx
Answering Reviewers	19213-Answering reviewers.pdf
Audio Core Tip	19213-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	19213-Conflict-of-interest statement.pdf
Copyright License Agreement	19213-Copyright assignment.pdf
Peer-review Report	19213-Peer-review(s).pdf
Scientific Misconduct Check	19213-Scientific misconduct check.pdf
Scientific Editor Work List	19213-Scientific editor work list.pdf